Literature DB >> 34372916

Gut micobiota alteration by Lactobacillus rhamnosus reduces pro-inflammatory cytokines and glucose level in the adult model of Zebrafish.

Fatemeh Bootorabi1, Farshid Saadat2, Reza Falak3, Hamed Manouchehri4, Reza Changizi4, Hasan Mohammadi5, Farnaz Safavifar6, Mohammad Reza Khorramizadeh7,8.   

Abstract

OBJECTIVE: Type 2 diabetes mellitus (T2DM) is still a challenge for physicians to manage patient's circumstances. It is assumed that alterations in the normal flora may be involved in the pathogenesis of T2DM through inducing chronic inflammation. To investigate the effect of Lactobacillus rhamnosus as a common probiotic on T2DM, we induced an experimental model of T2DM in adult male Zebrafish by gradient hyper-glucose accumulation methodology.
RESULTS: In this trial 3-month old male adult Zebrafish were divided in to four groups including two control groups and T2DM induced groups with or without probiotic treatment. After 5 days of acclimation, T2DM was induced by a gradient hyper-glucose accumulation methodology. Diabetic fishes had statistically abnormal blood glucose and pro-inflammatory cytokine levels compared to control group (p = 0.0001). These results suggest that probiotic intervention decreased the blood glucose level in the T2DM-P group by decreasing pro-inflammatory cytokines responsible for signaling in T2DM therapeutic modalities.
© 2021. The Author(s).

Entities:  

Keywords:  Cytokine; Lactobacillus rhamnosus; Probiotic; Type 2 diabetes mellitus (T2DM); Zebrafish

Year:  2021        PMID: 34372916     DOI: 10.1186/s13104-021-05706-5

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  32 in total

1.  Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.

Authors:  Livia Bordalo Tonucci; Karina Maria Olbrich Dos Santos; Leandro Licursi de Oliveira; Sonia Machado Rocha Ribeiro; Hercia Stampini Duarte Martino
Journal:  Clin Nutr       Date:  2015-12-07       Impact factor: 7.324

2.  The Microbiome and Risk for Obesity and Diabetes.

Authors:  Anthony L Komaroff
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

Review 3.  The Future of Diabetes Management by Healthy Probiotic Microorganisms.

Authors:  Aziz H Rad; Shamsi Abbasalizadeh; Shabnam Vazifekhah; Fatemeh Abbasalizadeh; Tohid Hassanalilou; Parvin Bastani; Hanieh-Sadat Ejtahed; Ahmad-Reza Soroush; Mina Javadi; Amir M Mortazavian; Leila Khalili
Journal:  Curr Diabetes Rev       Date:  2017

Review 4.  Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies.

Authors:  Hadi Atabati; Seyed-Alireza Esmaeili; Ehsan Saburi; Maedeh Akhlaghi; Amir Raoofi; Nima Rezaei; Amir Abbas Momtazi-Borojeni
Journal:  J Cell Physiol       Date:  2020-04-28       Impact factor: 6.384

5.  Beyond thriftiness: independent and interactive effects of genetic and dietary factors on variations in fat deposition and distribution across populations.

Authors:  Krista Casazza; Lynac J Hanks; T Mark Beasley; Jose R Fernandez
Journal:  Am J Phys Anthropol       Date:  2011-03-01       Impact factor: 2.868

6.  Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus-Part 1.

Authors:  Srikanth Yandrapalli; George Jolly; Adam Horblitt; Gayatri Pemmasani; Abdallah Sanaani; Wilbert S Aronow; William H Frishman
Journal:  Cardiol Rev       Date:  2020 Jul/Aug       Impact factor: 2.644

7.  Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes.

Authors:  S I Yun; H O Park; J H Kang
Journal:  J Appl Microbiol       Date:  2009-04-21       Impact factor: 3.772

8.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Authors:  Kristoffer Forslund; Falk Hildebrand; Trine Nielsen; Gwen Falony; Emmanuelle Le Chatelier; Shinichi Sunagawa; Edi Prifti; Sara Vieira-Silva; Valborg Gudmundsdottir; Helle K Pedersen; Manimozhiyan Arumugam; Karsten Kristiansen; Anita Yvonne Voigt; Henrik Vestergaard; Rajna Hercog; Paul Igor Costea; Jens Roat Kultima; Junhua Li; Torben Jørgensen; Florence Levenez; Joël Dore; H Bjørn Nielsen; Søren Brunak; Jeroen Raes; Torben Hansen; Jun Wang; S Dusko Ehrlich; Peer Bork; Oluf Pedersen
Journal:  Nature       Date:  2015-12-02       Impact factor: 49.962

9.  Effect of Cucurbita ficifolia and Probiotic Yogurt Consumption on Blood Glucose, Lipid Profile, and Inflammatory Marker in Type 2 Diabetes.

Authors:  Azade Bayat; Fatemeh Azizi-Soleiman; Motahar Heidari-Beni; Awat Feizi; Bijan Iraj; Reza Ghiasvand; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2016-02-02

10.  Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial.

Authors:  Leila Khalili; Beitullah Alipour; Mohammad Asghari Jafarabadi; Tohid Hassanalilou; Mehran Mesgari Abbasi; Ismail Faraji
Journal:  Diabetol Metab Syndr       Date:  2019-01-15       Impact factor: 3.320

View more
  1 in total

Review 1.  Application of zebrafish in the study of the gut microbiome.

Authors:  Xiaoting Zhong; Jinglin Li; Furong Lu; Jingjing Zhang; Lianxian Guo
Journal:  Animal Model Exp Med       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.